These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 15572980)
21. Toxicity with dextromethorphan-containing preparations: a literature review and report of two additional cases. Pender ES; Parks BR Pediatr Emerg Care; 1991 Jun; 7(3):163-5. PubMed ID: 1876508 [TBL] [Abstract][Full Text] [Related]
22. Coricidin HBP abuse: patient characteristics and psychiatric manifestations as recorded in an inpatient psychiatric unit. Dickerson DL; Schaepper MA; Peterson MD; Ashworth MD J Addict Dis; 2008; 27(1):25-32. PubMed ID: 18551885 [TBL] [Abstract][Full Text] [Related]
23. "DXM": a new drug of abuse? Nordt SP Ann Emerg Med; 1998 Jun; 31(6):794-5. PubMed ID: 9624331 [No Abstract] [Full Text] [Related]
24. Dextromethorphan abuse: clinical effects and management. Romanelli F; Smith KM J Am Pharm Assoc (2003); 2009; 49(2):e20-5; quiz e26-7. PubMed ID: 19289333 [TBL] [Abstract][Full Text] [Related]
26. Dextromethorphan: a case study on addressing abuse of a safe and effective drug. Spangler DC; Loyd CM; Skor EE Subst Abuse Treat Prev Policy; 2016 Jun; 11(1):22. PubMed ID: 27333886 [TBL] [Abstract][Full Text] [Related]
27. Index of suspicion. Dobson CP; Neuwirth M; Frye RE; Gorman M Pediatr Rev; 2006 Jan; 27(1):29-33. PubMed ID: 16387926 [No Abstract] [Full Text] [Related]
28. Chronic addiction to dextromethorphan cough syrup: a case report. Desai S; Aldea D; Daneels E; Soliman M; Braksmajer AS; Kopes-Kerr CP J Am Board Fam Med; 2006; 19(3):320-3. PubMed ID: 16672686 [TBL] [Abstract][Full Text] [Related]
29. Intentional Coricidin product exposures among Illinois adolescents. Yin S; Wahl M Am J Drug Alcohol Abuse; 2011 Nov; 37(6):509-14. PubMed ID: 21834605 [TBL] [Abstract][Full Text] [Related]
30. Ten Years of Robotripping: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User. Olives TD; Boley SP; LeRoy JM; Stellpflug SJ J Med Toxicol; 2019 Jul; 15(3):192-197. PubMed ID: 30903576 [TBL] [Abstract][Full Text] [Related]
31. Patterns and Perceptions of Dextromethorphan Use in Adult Members of an Online Dextromethorphan Community. Pringle G; McDonald MP; Gabriel KI J Psychoactive Drugs; 2015; 47(4):267-75. PubMed ID: 26266886 [TBL] [Abstract][Full Text] [Related]
32. Dextromethorphan. An overview of safety issues. Bem JL; Peck R Drug Saf; 1992; 7(3):190-9. PubMed ID: 1503667 [TBL] [Abstract][Full Text] [Related]
33. Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects. Shin EJ; Lee PH; Kim HJ; Nabeshima T; Kim HC J Pharmacol Sci; 2008 Jan; 106(1):22-7. PubMed ID: 18198471 [TBL] [Abstract][Full Text] [Related]
34. Adolescent substance use and abuse: recognition and management. Griswold KS; Aronoff H; Kernan JB; Kahn LS Am Fam Physician; 2008 Feb; 77(3):331-6. PubMed ID: 18297958 [TBL] [Abstract][Full Text] [Related]
35. Dextromethorphan. Banken JA; Foster H Ann N Y Acad Sci; 2008 Oct; 1139():402-11. PubMed ID: 18991887 [TBL] [Abstract][Full Text] [Related]